Incyte @Incyte Twitter profile

Last Seen Profiles

@bby31ia

@cukienaknikmati

@ly_933

@raytheard808

@aka99717868

@_coachaaron_

@abo_umoory

@whatsacoachella

@couples_mot7arr

@bythepocketful

@szn_yk

@Jesusurfer

@ma_kkcan

@WlfinSheepCl0th

@OnlineTestConf

@Shamara_Sex

@sasa_rosyo

@cukijilapepeena

@ociql5

@cha_genmai_cha

@NERDstar23

@pasutritobrut

@CoachTBush

@pasutritobrut

@DanielWrobel

@tar_mrmt

@BayarSafa

@Pithra_18

@DS6j5

@esquerdacidente

@anniethebunny09

@stwmaniax

@JordanTraylor

@pasutritobrut

@MlSSTWINPEAKS

Incyte

@Incyte

6 years

To all mothers, sisters, aunts, wives, grandmothers & daughters and all others affected by #breastcancer - we are continuously inspired by your strength & vow to help raise awareness. This #BCAM , visit @NBCF to learn more. #bcsm

24

547

1K

Incyte

@Incyte

5 years

At this year's #WVD2019Houston meeting, we had the opportunity to ask @leethomastv , founder of @vstrong_detroit , why and how he helps raise awareness for #vitiligo . Thanks for sharing your story to inspire others!

31

182

692

Incyte

@Incyte

7 years

September is #BloodCancerAwarenessMonth ! We're proud to stand with the MPN community to make a meaningful difference for patients.

15

221

483

Incyte

@Incyte

6 years

This #NCSD2018 , we honor cancer survivors & the caregivers by their side who continue to inspire our rigorous pursuit of science to create innovative medicines. #ASCO18

11

74

370

Incyte

@Incyte

2 years

Cancer research is fundamental to our work at Incyte. This month, we recognize National Cancer Research Month and thank our world-class scientists for their commitment to finding solutions for the serious unmet medical needs of our patients. #NCRM22 #ResearchSavesLives

National Cancer Research Month

incyte.com

16

95

363

Incyte

@Incyte

3 years

Founded in 2002, Incyte has dedicated nearly 20 years to creating innovative medicines in oncology and dermatology for patients. Looking ahead to 2022, we will continue our pursuit to Solve On.

Our Year in Review

incyte.com

16

41

303

Incyte

@Incyte

2 years

We asked #vitiligo advocates to describe in one word what a new FDA-approved treatment for vitiligo means to them. Here's what they said.

Impact of FDA Approval

incyte.com

16

37

300

Incyte

@Incyte

4 years

Jim Lee, M.D., Ph.D., Group Vice President, Inflammation & AutoImmunity explains how we are using our cross-functional knowledge of JAK inhibition in our #dermatology efforts to address the needs of people with #immune -mediated dermatologic conditions.

Our Growing Portfolio

incyte.com

13

65

335

Incyte

@Incyte

2 years

Paula Swain, our Executive Vice President of Human Resources, shares her perspective on Incyte being named a Top 100 Most Loved Workplace of 2022 by @Newsweek for the second year in a row. At Incyte, #WeSolveOn and it’s all made possible by our employees.

We Solve On.

incyte.com

28

39

287

Incyte

@Incyte

2 years

This #WorldBloodCancerDay , join us in raising awareness for people living with various blood cancers. We are proud to continue to support the blood cancer community through our research and development efforts. #WBCD

World Blood Cancer Day

incyte.com

12

89

263

Incyte

@Incyte

5 years

Living Dappled arms those with #vitiligo with education & inspiration to help them throughout their journey. We were able to connect with founder & patient advocate @erikapage at #WVD2019Houston to learn more about her work with & for the community.

4

52

248

Incyte

@Incyte

5 years

Our targeted therapy approach begins by uncovering what drives cells to become cancerous. This understanding helps us inform the design of molecules that directly or indirectly affect irregularities in cancer cells.

3

57

219

Incyte

@Incyte

7 years

There are over 6K existing #rarediseases . We're pursuing research that will provide hope for patients worldwide #ShowYourRare #CareAboutRARE

15

57

238

Incyte

@Incyte

3 years

This #WorldCancerDay and every day, we are committed to finding solutions for patients living with cancer. Learn more about our work in oncology.

World Cancer Day

incyte.com

14

44

224

Incyte

@Incyte

2 years

What’s it like living with #vitiligo ? Watch as Berardo shares his experience and his excitement for a new FDA-approved treatment option.

7

25

205

Incyte

@Incyte

2 years

We're thrilled to share that we've been recognized by @Newsweek as a Top 100 Most Loved Workplace for the second year in a row. Congratulations to our employees who foster a company culture built on collaboration, innovation and dedication to patients. #WeSolveOn #IncyteProud

We Solve On.

newsweek.com

6

29

202

Incyte

@Incyte

6 years

We explore combinations of therapies within and beyond our own portfolio with the aim to increase the effectiveness of single agents.

4

48

194

Incyte

@Incyte

6 years

Director, U.S. Medical Info, Ankur believes coming to Incyte gave him many opportunities to grow in his career and cultivate his innovative thinking. Hear why he chose #LifeAtIncyte .

0

33

197

Incyte

@Incyte

4 years

We're thrilled to open our new European headquarters in the Swiss city of Morges. We are looking forward to the increased collaboration & innovation this building will foster.

5

45

192

Incyte

@Incyte

2 years

We are proud that Incyte’s Hervé Hoppenot has been named a CEO of the Year by @DeBusinessTimes ! Thank you for your leadership and dedication to making a difference by empowering our team to find solutions for patients with unmet medical needs.

CEO of the Year

delawarebusinesstimes.com

7

62

190

Incyte

@Incyte

2 years

Jim Lee, Group VP, Inflammation and Autoimmunity at Incyte, shares his thoughts on the @FDA approval of our #vitiligo treatment.

6

27

176

Incyte

@Incyte

6 years

We know that scientific innovation cannot happen without the patients who participate in #clinicaltrials . Our colleague, Bill explains how patient involvement has evolved during his time at Incyte.

1

64

173

Incyte

@Incyte

4 years

Kimberly Boyd sheds light on the need for #vitiligo patient support and why she advocates for the vitiligo community, as a patient and member of the @StepUp4Vitiligo team. #VirtualWorldVitiligoDayUSA

3

52

179

Incyte

@Incyte

3 years

At Incyte, we are committed to making a meaningful difference in the lives of people living with rare diseases, like autoimmune hemolytic anemia (AIHA) as well as rare cancers. Learn more about how we Solve On. for patients this #RareDiseaseDay .

Rare Disease Day

incyte.com

10

51

163

Incyte

@Incyte

7 years

According to @LLSusa , approx. 173K Americans will be diagnosed w/ a #bloodcancer this yr #BloodCancerAwarenessMonth

13

107

168

Incyte

@Incyte

5 years

We aim to identify & target pathways in our inflammation & autoimmunity group that leads to the destruction of the body's own cells & tissues, striving to restore normal immune function to bring the body closer to homeostasis.

Our Commitment to IAI

incyte.com

9

51

180

Incyte

@Incyte

6 years

Our #immunooncology discovery strategy is based on enhancing the hosts immune response to treat cancer. #ASCO18

Discover Incyte's Science

incyte.com

2

29

182

Incyte

@Incyte

2 years

#Vitiligo impacts individuals in different ways. Dermatologist, Dr. Pearl Grimes MD ( @LAVitiligo ), and patient advocates, Bryson and Mobola, discuss why speaking with your dermatologist is essential.

This Is Vitiligo

thisisvitiligo.com

14

32

174

Incyte

@Incyte

6 years

We asked our Head of HR, Paula Swain, what she hopes to remember when looking back at her career one day. Hear her response. #LifeAtIncyte

4

33

169

Incyte

@Incyte

6 years

As Incyte continues to grow and evolve, following the science has remained at our core. Our CEO, Hervé Hoppenot, explains.

5

34

166

Incyte

@Incyte

3 years

We are presenting key data from our #oncology portfolio at #EHA2021 . Learn more.

Incyte at EHA 2021

ehaweb.org

5

11

152

Incyte

@Incyte

5 years

We are innovators. We are inquisitive researchers. We are critical thinkers. We are Incyte. Watch to discover what makes us who we are. #LifeAtIncyte

2

33

145

Incyte

@Incyte

6 years

Hear from our colleague & Director of Consumer Marketing Mary Beth Rush on how @VoicesofMPN seeks input & support from patients to provide the right tools & education for the MPN community. #Connect4MPNs #MPNsm

0

47

150

Incyte

@Incyte

3 years

Thousands of people around the world develop #cholangiocarcinoma ( #CCA ) each year. As a science-driven and patient-focused company, we aim to make a difference for CCA patients every day. #WorldCCADay

World CCA Day

incyte.com

6

34

157

Incyte

@Incyte

3 years

Our first Cryogenic Electron Microscopy (cryoEM) machine is advancing drug discovery research and helping us find solutions for patients with serious unmet medical needs through innovative technology.

4

21

134

Incyte

@Incyte

4 years

Data from our #oncology portfolio is being presented this week at the virtual @AACR Annual Meeting. Tune in to view key presentations. #AACR21

Join us at the AACR Annual Meeting

abstractsonline.com

3

26

151

Incyte

@Incyte

7 years

#ScienceSpotlight : We're exploring the role of the PI3Kδ molecule to inhibit B-cell growth and development

6

25

139

Incyte

@Incyte

6 years

Our employees take our commitment to patients very seriously. Hear what inspires Mary Beth Rush to #CareAboutRARE

2

46

144

Incyte

@Incyte

5 years

Our inflammation & autoimmunity scientists are exploring JAK inhibition to potentially treat a number of immune-mediated diseases.

Discover Our R&D Efforts

incyte.com

6

41

142

Incyte

@Incyte

6 years

Our teams are motivated by challenges because we know that great challenges can = great successes for patients. Research fellow, Eddy Yue talks about how we do things the 'Incyte way.'

Our Science

incyte.com

2

49

130

Incyte

@Incyte

3 years

This #BloodCancerAwarenessMonth we reaffirm our commitment to Solve On. Join us in raising awareness for those affected by blood cancers worldwide.

4

34

137

Incyte

@Incyte

5 years

Each year, @ASCO provides an inside look into outstanding breakthroughs in the field of #oncology . We look forward to #ASCO19 & connecting at booth #18063 .

0

19

121

Incyte

@Incyte

6 years

We're proud to partner with our local communities to further help people in need.

Discover Incyte Involved

incyte.com

0

24

125

Incyte

@Incyte

5 years

#Cholangiocarcinoma is often overlooked due to non-specific symptoms, which can lead to a late diagnosis. Hear from Incyte Chief Medical Officer, Steven Stein, about the importance of advancing research for this #raredisease . #WorldCCADay

2

37

126

Incyte

@Incyte

2 years

Next level treatments come from next level thinking. At Incyte, we’re thrilled to introduce our newly-approved treatment for #vitiligo . Learn more about how we #SolveOn for the dermatology community.

Solve On. For Vitiligo

incyte.com

2

13

119

Incyte

@Incyte

3 years

Check out key presentations on cholangiocarcinoma ( #CCA ) at the @GoHealio virtual panel discussion focusing on the current landscape of genomic alterations and biomarker testing.

3

16

117

Incyte

@Incyte

2 years

It’s #EmployeeAppreciationDay 🥳 and we are thrilled to showcase our talented team working to make a positive impact for patients. Thank you for all that you do! #IncyteProud

Employee Appreciation Day

incyte.com

0

18

118

Incyte

@Incyte

6 years

"Science first" is the principle on which Incyte was established and what continues to drive our work. Hear more from our colleague MaryAnne about #LifeAtIncyte

2

34

121

Incyte

@Incyte

4 years

This #RareCancerDay , hear from patients with an MPN and #CCA who share their stories and how they advocate for their health.

1

29

127

Incyte

@Incyte

2 years

This #WorldHealthDay , Steven Stein, Chief Medical Officer at Incyte, shares his perspective on the work Incyte is doing to advance scientific innovation and improve patient health. #HealthForAll

1

14

118

Incyte

@Incyte

6 years

Pivotal science remains a guiding force in our day-to-day work because we know that by following the science, innovation follows closely behind. Hear more from Incyte CEO, Hervé Hoppenot.

0

38

116

Incyte

@Incyte

2 years

On #InternationalWomensDay , we celebrate the significant role and impact of women around the world. We are committed to supporting efforts to #EmbraceEquity and foster an inclusive workplace. #IWD2023

9

20

109

Incyte

@Incyte

5 years

Our Chief Medical Officer, Steven Stein, explains how our inflammation & autoimmunity group uncovered the potential to address unmet needs in #vitiligo . Watch to learn more.

4

26

114

Incyte

@Incyte

7 years

#BREAKING : First patient treated in pivotal Ph. 3 clinical trial for acute graft-versus-host disease.

5

38

113

Incyte

@Incyte

5 years

What motivates our team? The potential to positively impact the lives of patients living with #cancer & other serious diseases by discovering, developing & delivering innovative medicines.

Join Our Innovative Team

incyte.com

4

24

112

Incyte

@Incyte

2 years

September is #BloodCancerAwarenessMonth . Follow us as we share stories of patients, their caregivers, and spotlight the incredible impact of our advocacy partners throughout the month as we #SolveOnForBloodCancer .

2

24

114

Incyte

@Incyte

6 years

Our ability to follow the science and achieve potential advances for patients relies on the expertise and perseverance of the people who make up our teams. Hear from our colleague Ankur Shah about #LifeAtIncyte .

0

44

104

Incyte

@Incyte

6 years

Precision medicine is not a one-size-fits-all approach. So we constantly evolve our R&D efforts and clinical development strategies to find the right targets.

3

27

107

Incyte

@Incyte

5 years

We're proud to announce that our Head of Human Resources, Paula Swain, has won the @DeBusinessTimes 2019 HR Executive of the Year Award. Congratulations to her & all other nominees for their outstanding leadership. #WomanInScience #DEHRAwards

6

18

100

Incyte

@Incyte

7 years

We're heading to #ASH17 to present new clinical data & connect w/ the #hematology community about advancements in the space. See you in ATL!

7

28

93

Incyte

@Incyte

5 years

Incyte's culture is one of agility and collaboration. Our colleague, Bill, explains what makes #LifeAtIncyte special.

1

21

89

Incyte

@Incyte

5 years

Our senior leaders Maria Pasquale and Paula Swain share their #HBAImpact & discuss what they believe helped them propel their careers. Learn more via @HBAnet .

0

17

96

Incyte

@Incyte

7 years

Rare diseases are not so rare after all. Our colleagues #CareAboutRARE to support the 350MM affected by a #raredisease worldwide #RareDiseaseDay

2

23

98

Incyte

@Incyte

5 years

We're sharing comprehensive genomic profiling findings from our trial highlighting the landscape of actionable alterations in cholangiocarcinoma. Poster sessions begin in 30 minutes. #ASCO19

2

13

89

Incyte

@Incyte

5 years

Jim Lee, Group VP & Head of Inflammation & Autoimmunity, explains how we're utilizing our expertise of the JAK pathway as we seek to address unmet needs for people with #vitiligo . #EADV2019

1

24

88

Incyte

@Incyte

2 years

We’re honored to have been named a 2022 Top Employer by @ScienceMagazine for the 5th consecutive year! Paula Swain, Executive Vice President, Human Resources, shares more about Incyte’s culture. #SCTopEmployer

We Solve On.

science.org

6

3

95

Incyte

@Incyte

8 years

In honor of #RareDiseaseDay , our colleagues are joining hands to show their support & help raise awareness! How do you show your support?

0

31

92

Incyte

@Incyte

6 years

Our efforts extend beyond the lab to further serve our local communities. Learn more about #IncyteInvolved .

Incyte Involved

incyte.com

0

20

87

Incyte

@Incyte

2 years

Dr. Srdan Verstovsek, Professor of Medicine, Department of Leukemia, University of Texas MD Anderson Cancer Center, shares his perspective on the importance of Incyte’s CALR discovery research presented at #ASH22 .

4

16

90

Incyte

@Incyte

3 years

In honor of #Cholangiocarcinoma ( #CCA ) Awareness Month, learn more about the importance of biomarker testing through these interviews with key experts in the space at @GoHealio .

Learn More About CCA

healio.com

2

22

78

Incyte

@Incyte

2 years

Peter Langmuir, Vice President of Oncology Drug Development at Incyte, discusses what to expect from Incyte at #ASH22 . Follow along to learn more about our data and key presentations at the @ASH_hematology Annual Meeting.

3

12

75

Incyte

@Incyte

6 years

Our core strength & innovative #science lies in the experience and passion of our growing team.

Be a part of the culture at Incyte

incyte.com

6

7

80

Incyte

@Incyte

5 years

Looking forward to attending #ESMO19 over the next few days. Follow along to discover our latest #oncology research.

ESMO 2019

esmo.org

3

20

82

Incyte

@Incyte

7 years

It takes time & perseverance to discover, develop & deliver a medicine to patients in need. Learn more about our R&D process.

How we do science

incyte.com

6

11

83

Incyte

@Incyte

4 years

Our inflammation & autoimmunity (IAI) research team utilizes its cross-functional knowledge of our programs to discover, develop & deliver innovative approaches to treating immune-mediated diseases.

Learn How We Innovate

incyte.com

4

15

84

Incyte

@Incyte

6 years

Our #targetedtherapy discovery strategy emphasizes the pursuit of therapeutic intervention points that lie in interdependent oncogenic pathways.

1

15

73

Incyte

@Incyte

6 years

Our Head of HR, Paula Swain, weighs in on #LifeAtIncyte & what sets our culture apart as a 2018 Top Employer by @ScienceMagazine .

incyte.com

0

18

71

Incyte

@Incyte

6 years

Since the beginning, Incyte has been defined by our people, mission, science and passion. This is Incyte!

1

25

74

Incyte

@Incyte

1 year

It’s #VitiligoAwarenessMonth . Learn more about this autoimmune condition and help spread awareness by educating others. #SolveOnForVitiligo

Vitiligo Awareness Month

thisisvitiligo.com

1

9

72

Incyte

@Incyte

5 years

#ESMO19 News: We've announced positive updated results from our Phase 2 trial in cholangiocarcinoma.

Read The Full Announcement

incyte.com

1

17

72

Incyte

@Incyte

8 years

Join us in the fight against #cancer w/ @SarahCannonTour & learn about Voices of MPN

1

26

64

Incyte

@Incyte

5 years

At Incyte, we believe the most interesting science stems from the patient's impact. Hear from Head of HR, Paula Swain, on what motivates our work. #LifeAtIncyte

1

19

62

Incyte

@Incyte

6 years

#BloodCancerAwarenessMonth starts in a few short weeks. Stay tuned for ways to help raise awareness of MPNs and other blood cancers. #BCAM #mpnsm

0

32

68

Incyte

@Incyte

2 years

Understanding the science behind #AtopicDermatitis can help you and your dermatologist better manage the condition. Learn more about the root cause of AD from Dr. Rebecca Smith, Board Certified Dermatologist, and visit . #NationalEczemaAwarenessMonth

National Eczema Awareness Month

startfromscratch.com

4

13

65

Incyte

@Incyte

5 years

Hear from our colleague Jim Lee, Group Vice President, Head of Inflammation & Autoimmunity, on how we're utilizing JAK inhibition to drive R&D efforts for people with immune-mediated diseases. #ADAM20

Discover Our IAI Research

incyte.com

0

12

72

Incyte

@Incyte

3 years

We look forward to showcasing data from our #oncology portfolio and partner programs at the #ASCO21 congress kicking off today.

Incyte at ASCO 2021

asco.org

2

10

67

Incyte

@Incyte

5 years

#ScienceSpotlight : We are investigating molecules that have the potential to be important targets in hematologic malignancies as well as solid tumors.

Discover Our Science

incyte.com

3

15

65

Incyte

@Incyte

2 years

#Breaking : The @US_FDA has approved our treatment for #vitiligo .

Read the Announcement  

incyte.com

6

19

70

Incyte

@Incyte

6 years

Incyte #ASCO18 presentation information all in one place. Visit us at booth #20081 to learn more about our portfolio of targeted therapies and immuno-therapies.

0

6

62

Incyte

@Incyte

2 years

Edimara Reis, Associate Director, Antibody Pharmacology at Incyte, unveiled Incyte's research at the plenary session, illustrating how we are uniquely positioned to advance science for patients with MPNs. #ASH22

3

7

66

Incyte

@Incyte

2 years

At Incyte, we are on a mission to change patients’ lives. While we are dedicated to supporting those in the vitiligo community every day, it is especially important to do so at key moments like #WorldVitiligoDay . Read more.

1

15

62

Incyte

@Incyte

4 years

October is #NationalEczemaAwarenessMonth . We remain committed to addressing the unmet needs of those who have #atopicdermatitis . Learn about @nationaleczema 's initiative & join us in raising awareness.

National Eczema Awareness Month

nationaleczema.org

2

20

64

Incyte

@Incyte

5 years

Rigorous science is at the core of our operations, driving our discovery, development and delivery of novel medicines with the potential to improve patients' lives.

2

15

57

Incyte

@Incyte

5 years

We have a broad and diversified selection of targets within our growing portfolio in the fields of oncology, inflammation and autoimmunity.

0

14

58

Incyte

@Incyte

6 years

#LifeAtIncyte is fueled by the ability to adapt to change while working with efficiency and precision. Our colleague Bill weighs in.

2

27

55

Incyte

@Incyte

7 years

Our discovery capabilities, expanded geographic footprint & ever-growing portfolio position us to create long-term value.

We are Incyte

incyte.com

1

14

58

Incyte

@Incyte

3 years

We’re excited to announce the opening of our BioPlant in Yverdon, Switzerland. This milestone underscores our investment in strong science and our commitment to finding innovative solutions that positively impact patients’ lives.

7

62

Incyte

@Incyte

3 years

At #ASCO21 , we will be presenting FIGHT-202 study updates highlighting one of our approved therapies for previously treated locally advanced/metastatic #cholangiocarcinoma .